Shionogi & Co., Ltd.’s fiscal year ending March 2026 reported sales of JPY 499.7 billion (up 14.0% YoY), operating profit is unspecified, net income increased by 21.5% to JPY 205.9 billion. Overseas sales have also grown significantly.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4507","jir_company_name":"Shionogi & Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-05-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4507-20260512-02.pdf","jir_short_summary":"Shionogi & Co., Ltd.'s fiscal year ending March 2026 reported sales of JPY 499.7 billion (up 14.0% YoY), operating profit is unspecified, net income increased by 21.5% to JPY 205.9 billion. Overseas sales have also grown significantly.","jir_summary":"### Performance Overview\nShionogi & Co., Ltd.'s consolidated net sales for the fiscal year ending March 2026 reached JPY 499.7 billion, representing a 14.0% increase YoY, with overseas sales also robust at JPY 65 billion. Although detailed figures for gross profit and operating profit are not provided, net income rose by 21.5% to JPY 205.9 billion, indicating improved profitability. Research and development expenses and sales, general and administrative expenses have increased, reflecting ongoing investments in new drugs and vaccines. Future outlooks and forecast achievement ratios are also presented.\n\n### Impact on Shareholders and Future Outlook\nWith increases in sales and net income, shareholder returns and dividend increases are expected. Growth prospects are supported by overseas expansion and development of new drugs. The company's financial position remains solid; although share buyback and capital policy movements are not detailed, future business strategies are attracting attention.","jir_financial_highlights":"Net Sales: JPY 499.7 billion (Up 14.0% YoY)\nNet Income: JPY 205.9 billion (21.5% increase)\nOverseas Subsidiaries\/Export Sales: JPY 65 billion (9.9% increase)","jir_category":"","jir_hashtags":"#Shionogi, #IRSystem, #JapaneseStocks","jir_key_figures":"Net Sales: JPY 499.7 billion (Up 14.0% YoY)\nNet Income: JPY 205.9 billion (21.5% increase)\nOverseas Subsidiaries\/Export Sales: JPY 65 billion (9.9% increase)","jir_meta_title":"\u3010Shionogi & Co., Ltd.\u30112026 Financial Results | Sales of JPY 499.7 billion (Up 14.0% YoY)","jir_meta_description":"Shionogi & Co., Ltd.'s fiscal year ending March 2026 reported sales of JPY 499.7 billion and net income of JPY 205.9 billion, with increased revenue and profit. Overseas expansion is also progressing, fueling expectations for future growth.","jir_og_title":"\u3010Shionogi & Co., Ltd.\u30112026 Financial Results | Sales of JPY 499.7 billion (Up 14.0% YoY)","jir_og_description":"Shionogi's 2026 financial results show strong sales and net profit growth. Overseas sales are expanding, and long-term growth prospects are high.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6919,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-48153","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n